Zeng Ying, Zhang Yong, Zhang Jing, Jian Wei, Li Rongqing, Fu Qiaofen
Department of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
Oncol Lett. 2023 Aug 22;26(4):433. doi: 10.3892/ol.2023.14020. eCollection 2023 Oct.
Central nervous system (CNS) malignant melanomas are rare tumors of the CNS that are thought to arise from aberrant changes in melanocytes of the neural crest or melanocytic elements of the pia mater during early embryonic development. As a rare type of CNS malignant melanoma, only a few cases of primary malignant melanoma in the spinal canal have been reported thus far. The majority of these studies have reported on the diagnosis, radiographic features and gross total resection of primary spinal canal malignant melanoma; however, the prognosis and ideal treatment of patients with residual tumors remain elusive. The current study presented the rare case of a patient with primary malignant melanoma originating from the thoracic spinal canal, without any history of irradiation exposure and with an incompletely resected tumor. Disease-free survival of >2.5 years was observed in this patient who was treated with concurrent chemoradiotherapy followed by adjuvant chemotherapy with temozolomide and bevacizumab.
中枢神经系统(CNS)恶性黑色素瘤是中枢神经系统的罕见肿瘤,被认为起源于胚胎早期发育过程中神经嵴黑素细胞或软脑膜黑素细胞成分的异常变化。作为一种罕见的中枢神经系统恶性黑色素瘤类型,迄今为止仅报道了少数几例椎管原发性恶性黑色素瘤病例。这些研究大多报道了原发性椎管恶性黑色素瘤的诊断、影像学特征和大体全切情况;然而,残留肿瘤患者的预后和理想治疗方法仍不明确。本研究报告了一例罕见病例,该患者患有起源于胸段椎管的原发性恶性黑色素瘤,无任何放疗暴露史,肿瘤切除不完全。该患者接受同步放化疗,随后用替莫唑胺和贝伐单抗进行辅助化疗,观察到无病生存期超过2.5年。